about
Customized targeted therapy in Hodgkin lymphoma: hype or hope?Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationGenomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin's Lymphoma.Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases.Unusual primary osseous Hodgkin lymphoma in rib with associated soft tissue mass: a case report and review of literatureThe Drosophila Accessory Gland as a Model for Prostate Cancer and Other Pathologies.Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review.Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing.Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.Peptide matching between Epstein-Barr virus and human proteins.Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.Epstein-Barr virus-associated lymphomas
P2860
Q27002554-C1F93AEE-F24A-4A92-8272-14BC863F32A9Q28731826-CE36EB1A-1086-44D9-8E02-E466497EEC9FQ31143601-77E8E63E-CCBE-4536-B2F3-822AB4F25FDAQ33416615-0CB58D17-59A1-4B22-A1AA-6DFFE9AAE1EEQ33435995-71AE66D8-427A-4A82-A943-6416535DF0F8Q35639424-9652AC99-DF28-4B7F-A269-5F584BE6E88DQ36150869-0C6271A1-D2A2-4754-9BED-A746B8E167A3Q36299221-34DDAD4A-B0F6-409D-82AD-745F19D6D218Q37577716-805961E9-A857-40F4-8E85-DD0C606088B8Q38039425-A0AB369F-5340-490B-99B2-F6504B0C1281Q38044928-DB7621E1-8E86-47D2-A80C-52721ECE4916Q38085250-FD36B827-6838-49FF-A166-9BCEC0DF743DQ38947120-017FA408-41A1-4660-B064-4E7A64A9FE3BQ39148654-2AF061A1-85A2-4B46-9DDF-35496459B951Q40538712-58C5D0D4-1B3B-40EA-8136-D5420A7714CCQ42183852-0D289506-74FA-4496-A8F6-EFA7F5EBD3ADQ42225310-4AB498FC-49FE-43B6-A488-C54A3EBD2C9AQ42282416-9A6A3CC5-8F77-470A-8E94-81DCB95C0FD6Q43872764-CC8120EF-901C-4969-A8F6-C30BD787CB49Q56930876-8BA8ADF4-A2D2-46AE-83E2-E11C1ECB1415
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The molecular pathogenesis of Hodgkin lymphoma.
@ast
The molecular pathogenesis of Hodgkin lymphoma.
@en
The molecular pathogenesis of Hodgkin lymphoma.
@nl
type
label
The molecular pathogenesis of Hodgkin lymphoma.
@ast
The molecular pathogenesis of Hodgkin lymphoma.
@en
The molecular pathogenesis of Hodgkin lymphoma.
@nl
prefLabel
The molecular pathogenesis of Hodgkin lymphoma.
@ast
The molecular pathogenesis of Hodgkin lymphoma.
@en
The molecular pathogenesis of Hodgkin lymphoma.
@nl
P2860
P1433
P1476
The molecular pathogenesis of Hodgkin lymphoma
@en
P2093
Katrina Farrell
P2860
P356
10.1111/J.1365-2559.2010.03705.X
P577
2011-01-01T00:00:00Z